Journal article
Intraocular bevacizumab in the treatment of choroidal metastases from breast cancer
BMJ Case Reports, Vol.2016
07/18/2016
DOI: 10.1136/bcr-2016-215719
PMID: 27435845
Abstract
Description:
We report the case of a 38-year-old woman who was initially diagnosed with stage II oestrogen receptor (ER) positive, progesterone receptor (PR) positive, human epidermal growth factor receptor 2 (HER2) negative infiltrating ductal carcinoma of the breast, in 2013. Breast MRI at that time showed multifocal disease in the right breast. The patient underwent a right mastectomy and axillary lymph node dissection, which revealed pT2 N1a breast cancer. Following this, she received four cycles of docetaxel and cyclophosphamide and adjuvant radiation. At that time, she had declined tamoxifen due to her history of lattice degeneration and concerns of retinal detachment. She was also offered letrozole with goserelin but declined due to their side effect profile and risk for retinal complications.
Details
- Title: Subtitle
- Intraocular bevacizumab in the treatment of choroidal metastases from breast cancer
- Creators
- José Pablo Leone - University of IowaKalyan Nadiminti - University of Iowa
- Resource Type
- Journal article
- Publication Details
- BMJ Case Reports, Vol.2016
- DOI
- 10.1136/bcr-2016-215719
- PMID
- 27435845
- NLM abbreviation
- BMJ Case Rep
- ISSN
- 1757-790X
- Copyright
- Copyright 2016 BMJ Publishing Group
- Language
- English
- Date published
- 07/18/2016
- Academic Unit
- Internal Medicine
- Record Identifier
- 9983557139202771
Metrics
156 File views/ downloads
48 Record Views